Document is current
Any future updates will be listed below
-
Authors
Derman, Benjamin A.
Major, Ajay https://orcid.org/0000-0001-7261-1335
Cooperrider, Jennifer
Jiang, Ken
Ramsland, Aubrianna
Karrison, Theodore
Kubicki, Tadeusz https://orcid.org/0000-0001-7588-1453
Jakubowiak, Andrzej J.
-
Funding
Funding for this research was provided by:
Multiple Myeloma Research Foundation
- License Information
-
More Information
Article History
Received: 26 June 2024
Revised: 22 September 2024
Accepted: 25 September 2024
First Online: 7 October 2024
Competing interests
: B.A.D. declares consultancy for Johnson & Johnson, Sanofi, Canopy, and Cota Inc.; independent clinical trial reviewer for BMS; research funding from GSK and Amgen. A.M., J.C., K.J., A.R., Th.K., and Ta.K. have nothing to disclose. A.J.J. declares honoraria and advisory board fees from Abbvie, Amgen, Bristol-Myers Squibb/Celgene, GlaxoSmithKline, Gracell, Janssen, and Sanofi.
